Grants per year
Personal profile
Training Experience
| 1997 | Residency, Universite Libre De Bruxelles, Belgium |
| 1999 | Postdoctoral Fellowship, Yale University |
| 2003 | Residency, Yale University |
| 2006 | Fellowship, Montefiore Medical Center |
Education/Academic qualification
MHA, Columbia University
… → 2016
MD, Universite Libre de Bruxelles, Belgium
… → 1992
Fingerprint Dive into the research topics where Shohreh Shahabi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Ovarian Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Down Syndrome
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Tubulin
Medicine & Life Sciences
Databases
Medicine & Life Sciences
Endometrial Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2013 2023
Implementation and Evaluation of an Expanded Bilingual Electronic Symptom Management Program across a Multi-site, Fully-integrated Comprehensive Cancer Center
Bass, M., Bilimoria, K. Y., Cella, D., Garcia, S. F., Kallen, M. A., Kircher, S. M., Penedo, F. J., Scholtens, D. M., Shahabi, S., Smith, J. D., Wehbe, F. & Yanez, B. R.
9/24/18 → 6/30/23
Project: Research project
Delivery of Health Care
Neoplasms
Patient Participation
Standard of Care
Informatics
Targeting Lipid Unsaturation in Ovarian Cancer Stem Cells
Chakravarti, D., Condello, S., Matei, D. E., Shahabi, S. & Wei, J.
8/1/18 → 7/31/23
Project: Research project
Neoplastic Stem Cells
Ovarian Neoplasms
Lipids
Heterografts
Raman Spectrum Analysis
Prot #STU00206173: c-Met: A Potential Target for the Treatment of Advanced Ovarian Cancer
Kocherginsky, M., Matei, D. E. & Shahabi, S.
12/1/17 → 12/1/19
Project: Research project
Ovarian Neoplasms
Drug Therapy
Neoplasms
Non-Small Cell Lung Carcinoma
Disease Progression
Epigenomic Priming as an Immunotherapy Enhancer in Ovarian Cancer
Kocherginsky, M., Matei, D. E., Shahabi, S., Wei, J. & Zhang, B.
U.S. Army Medical Research and Materiel Command
5/1/17 → 4/30/20
Project: Research project
Epigenomics
Ovarian Neoplasms
Immunotherapy
Neoplasms
Neoplasm Antigens
Prot #D0818C00001/GOG-3004: A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chem
DrugDev Inc., AstraZeneca Pharmaceuticals LP
6/19/14 → 8/31/18
Project: Research project
Research Output 1997 2019
3
Citations
(Scopus)
Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer
Goodman, C. R., Hatoum, S., Seagle, B. L. L., Donnelly, E. D., Barber, E., Shahabi, S., Matei, D. E. & Strauss, J. B., Apr 1 2019, In : Gynecologic oncology. 153, 1, p. 41-48 8 p.Research output: Contribution to journal › Article
Endometrial Neoplasms
Radiotherapy
Drug Therapy
Survival
Therapeutics
Significance of number of positive lymph nodes and size as prognostic factors of recurrence and overall survival in cervical cancer patients
Attiah, D. G., Helenowski, I., Refaat, T., Strauss, J. B., Shahabi, S., Lurain III, J. R., Pineda, M., Nieves-Neira, W., Matei, D. E. & Donnelly, E. D., Jan 1 2019, In : European Journal of Gynaecological Oncology. 40, 4, p. 609-613 5 p.Research output: Contribution to journal › Article
Uterine Cervical Neoplasms
Lymph Nodes
Recurrence
Survival
Radiotherapy
2
Citations
(Scopus)
Survival After Minimally Invasive Radical Hysterectomy for Early-stage Cervical Cancer
Melamed, A., Margul, D. J., Chen, L., Keating, N. L., Del Carmen, M. G., Yang, J., Seagle, B. L. L., Alexander, A., Barber, E., Rice, L. W., Wright, J. D., Kocherginsky, M., Shahabi, S. & Rauh-Hain, J. A., Feb 1 2019, In : Obstetrical and Gynecological Survey. 74, 2, p. 84-85 2 p.Research output: Contribution to journal › Comment/debate
Hysterectomy
Uterine Cervical Neoplasms
5
Citations
(Scopus)
21-gene recurrence score assay predicts benefit of post-mastectomy radiotherapy in T1-2 N1 breast cancer
Goodman, C. R., Seagle, B. L. L., Kocherginsky, M., Donnelly, E. D., Shahabi, S. & Strauss, J. B., Aug 15 2018, In : Clinical Cancer Research. 24, 16, p. 3878-3887 10 p.Research output: Contribution to journal › Article
Mastectomy
Radiotherapy
Breast Neoplasms
Recurrence
Genes
21
Citations
(Scopus)
Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer
Goodman, C. R., Seagle, B. L. L., Friedl, T. W. P., Rack, B., Lato, K., Fink, V., Cristofanilli, M., Donnelly, E. D., Janni, W., Shahabi, S. & Strauss, J. B., Aug 1 2018, In : JAMA Oncology. 4, 8, e180163.Research output: Contribution to journal › Article
Circulating Neoplastic Cells
Radiotherapy
Breast Neoplasms
Survival
Databases